San Francisco | June 1, 2021 - Together with Aligning Science Against Parkinson’s (ASAP), and the Michael J. Fox Foundation for Parkinson’s Research, NysnoBio and its founder Dr. Jennifer A. Johnston announce the launch of an innovative, multi-year study into the most common genetic causes of Parkinson’s Disease (PD).

The lack of tailored treatments for sufferers of Young Onset Parkinson’s Disease (YOPD) has destroyed countless lives. The good news: recent advances at NysnoBio may point toward a gene-based cure for YOPD, as well as late-Onset Parkinson’s and other challenging CNS disorders.

Dr. Deniz Kirik (Lund University), Dr. Matt Goldberg (University of Alabama at Birmingham), and Dr. Jennifer Johnston (NsynoBio and NysnoBioMetriX) proudly announce continued funding from The Michael J. Fox Foundation (MJFF) for work to benefit the broader Parkinson’s community. This new study

In partnership with Aligning Science Across Parkinson's (ASAP) and The Michael J. Fox Foundation (MJFF), NysnoBio and its non-profit arm NysnoBioMetriX (NBX) are proud to announce the launch of a novel, patient-driven data repository supporting the newly launched ASAP Collaborative Research Network.